Vimarsana
Biggest News Aggregation in the World

While Glenmark News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from While Glenmark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In While Glenmark Today - Breaking & Trending Today

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray - Vimarsana News

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris™ Nasal Spray Posted On: 2020-12-22 20:36:41 (Time Zone: Arizona, USA) Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris™ across 33 countries in Europe, including the Balkan region. Ryaltris™ [olopatadine hydrochloride (665 mcg...

Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe - Vimarsana News

Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe

Glenmark Pharmaceuticals Ltd Glenmark Pharmaceuticals and Menarini enter into exclusive licensing agreement for commercializing Ryaltris™ nasal spray across numerous markets throughout Europe ANI | Updated: Dec 23, 2020 11:14 IST Mumbai (Maharashtra) [India] December 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty SA, has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its i...

Source: aninews.in
Glenmark to commercialize Ryaltris™ nasal spray throughout Europe - Vimarsana News

Glenmark to commercialize Ryaltris™ nasal spray throughout Europe

Glenmark to commercialize Ryaltris™ nasal spray throughout Europe Glenmark to commercialize Ryaltris™ nasal spray throughout Europe 23 December 2020 | News Source credit: Shutterstock Glenmark Pharmaceuticals Ltd, a research-led global integrated pharmaceutical company, has announced that its Swiss subsidiary, Glenmark Specialty SA, has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercialising its innovative nasal spray Ryaltris™ across 33 countries in Europe, including the Balkan region. Ryaltris™ [olopatadine hydrochloride (665 mcg) and...

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing - Vimarsana News

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing

Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing MUMBAI, India, Dec 23, 2020 /PRNewswire/ -- Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led global integrated pharmaceutical company, today announced that its Swiss subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Menarini Group (Menarini) for commercializing its innovative nasal spray Ryaltris™ across 33 countries in Europe, including the Balkan region. Ryaltris™ [olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)]...

Glenmark Inks Pact With Menarini Group To Commercialise Nasal Spray In Europe - Vimarsana News

Glenmark Inks Pact With Menarini Group To Commercialise Nasal Spray In Europe

Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe The company's product is a novel fixed-dose combination nasal spray of an antihistamine and a steroid, indicated for treatment of symptoms associated with seasonal allergic rhinitis (SAR) in patients over 12 years of age. PTI December 23, 2020 / 11:38 AM IST Glenmark Pharmaceuticals on Wednesday said its subsidiary has inked a licensing pact with Menarini Group for commercialising its nasal spray Ryaltris across 33 countries in Europe, including the Balkan region. Glen...